feed,title,long_url,short_url
Benzinga,APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401,https://www.benzinga.com/pressreleases/20/07/n16546333/apeiron-biologics-and-maxcyte-enter-into-clinical-and-commercial-licensing-agreement-for-apn401,https://j.mp/2O74G6Q
